Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluating the Safety and Immunogenicity of MTBVACActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosisRecruitingPhase 22026-03-12NCT05947890

4 results · Page 1 of 1

Swipe the table sideways for more columns.

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cape Town - EmavundleniCape TownSouth Africa1
Cape Town - Groote SchuurCape TownSouth Africa1
Cape Town - KhayelitshaCape TownSouth Africa1
Cape Town - UCTLICape TownSouth Africa1
Durban - Botha's Hill CRSDurbanSouth Africa1
Durban - ChatsworthChatsworthSouth Africa1
Durban - IsipingoIsipingoSouth Africa1
Durban - WentworthDurbanSouth Africa1
Durban eThekwiniDurbanSouth Africa1
Johannesburg - CHRUWestdeneSouth Africa1
KlerksdorpKlerksdorpSouth Africa1
LadysmithLadysmithSouth Africa1
Rustenburg CRSRustenburgSouth Africa1
SoshanguveSoshanguveSouth Africa1
Soweto - GautengJohannesburgSouth Africa1
Worcester - SATVIWorcesterSouth Africa1